EVIDENCE LIBRARY
All our research, in one place, with its level of evidence.
Filter by division. Every entry says what was tested, in what model, and whether results are in. Full reports come with each division's technical annex.
HUMAN · EX-VIVO / IN-VITRO · PRECLINICAL IN-VIVO · ANALYTICAL · PROPOSED
COCOFIB™ · HUMAN
Glycemic and lipid response to Cocozyme-processed coconut fiber
Lower glycemic response and reductions in cholesterol and triglycerides with coconut-flour material made with the same enzymatic technology.
DOST-FNRI / Trinidad et al. · Earlier coconut-fiber material · Completed
COCOFIB™ · EX-VIVO
Butyrate and microbiome response at 1 g/day-equivalent
Butyrate response comparable to the tested high-dose inulin condition (2.5 g/day-equivalent); selective increase of Roseburia faecis.
Cryptobiotix SIFR® human-donor gut model · CocoFib-specific · Completed
COCOFIB™ · PRECLINICAL
Metabolic markers in a diet-induced obesity model
The lowest tested dose significantly improved glucose tolerance, insulin sensitivity and adiposity in mice.
Enterosys · Mouse model · CocoFib-specific · Completed
COCOFIB™ · IN-VITRO
In-vitro fermentation report
Fermentation testing of CocoFib™ in the laboratory. Full report included in the CocoFib™ annex.
Monash University · Completed
COCOIN™ · ANALYTICAL
Composition and microbiology of a representative lot
43.80% dietary fiber, 20.89% protein, 14.1% mannose post-hydrolysis; pathogens negative.
Eurofins Experchem · Report AR-26-TR-033448 · 2026
ANIMAL SCIENCE
Alternatives to antibiotics against ETEC F4 in a pig intestinal model
In-vitro model with full-length 16S sequencing, designed to evaluate CocoFib's effect.
Université de Montréal · Prof. Alexandre Thibodeau, PhD
ANIMAL SCIENCE
CocoFib in salmon: gut microbiome, health and pathogen challenge
A proposed experimental design to assess CocoFib in salmon feed, with gut-microbiome and health endpoints and a pathogen challenge.
Dalhousie University · Atlantic Veterinary College · with NRC Canada